Transforming Intellectual Property into Strategic Business Assets
At COZAREN, we help innovators, investors, and executives unlock the full value of their intellectual property. From patent portfolio optimisation and IP competitive intelligence to AI biosequence search platforms, we deliver insights and strategies that maximise return on innovation, mitigate risk and accelerate market success.
Company Capabilities Overview
Patent and Competitive Intelligence Searches
Effective decisions start with the right data. Our patent search services and market intelligence solutions provide critical insights for IP strategy, M&A, biopharma licensing and investment due diligence.
​
We deliver:
-
Novelty and patentability searches to validate innovation before filing.
-
Validity and opposition searches to strengthen patent enforcement and defence.
-
Freedom-to-operate (FTO) analyses to avoid infringement disputes before product launch.
-
IP landscape and trend mapping to benchmark competitors and uncover whitespace opportunities.
Patent Portfolio Optimisation & Licensing Opportunity Identification
Your patents should drive business growth, not just sit in a database. We align your intellectual property strategy with your commercial objectives, ensuring every asset supports revenue generation, risk reduction and long-term value creation.
​
Our IP portfolio management services include:
-
Enforcing patent rights through licensing or litigation when infringement occurs.
-
Reducing exposure with early infringement and litigation risk assessments.
-
Accelerating biopharma product development and Swiss market entry by connecting you with venture capital and local investors.
-
Identifying high-value licensing prospects, viable markets and R&D collaboration partners.
-
Monetising non-core patents and underused IP through licensing, technology transfer, divestiture or alternative financing.
-
Conducting competitive intelligence analyses to guide strategic pruning and reduce operational costs.
Due Diligence Support for IP Transactions
High-stakes deals require precise, risk-informed insights. We provide end-to-end IP due diligence services in collaboration with experienced patent attorneys, covering the full intellectual property lifecycle. Our approach ensures stakeholders have a clear, actionable understanding of IP assets, liabilities and opportunities.
​
We support:
-
Licensing and acquisition evaluations.
-
Investment and partnership negotiations.
-
R&D collaborations and joint ventures.
-
Regulatory and commercialisation readiness assessments.
AI-Integrated Biosequence Search Platforms
We design, build and manage advanced bioinformatics search platforms that combine AI with gold-standard algorithms like BLAST and Smith-Waterman. In partnership with expert engineers, we deliver scalable, high-performance tools for IP, R&D and regulatory teams. Our bespoke AI-assisted biosequence search solutions streamline complex workflows, improving speed, accuracy and decision-making.
​
Platform capabilities:
-
High-precision protein and nucleotide sequence searches.
-
CDR (complementarity-determining region) searches for proteins and nucleotides.
-
Motif-based searches allowing up to five mismatches.
-
Hybrid searches combining sequence data with keyword filters for targeted results.
​
About Cornelius Enuezie
Cornelius Enuezie, founder of COZAREN GmbH, leverages more than 28 years of experience in biopharmaceutical and agrochemical patents and industry leadership—including roles at Novartis, IMS Health, Teva, and Clarivate—to strengthen and elevate your IP strategy.
Proven ability to utilise technical knowledge, business acumen, specialist patent search and competitive intelligence research skills to facilitate an excellent record of building effective licensing and patent monetisation programmes and supplementing the revenue-generating activities of biopharmaceutical organisations.
Qualifications
-
Doctorate in Business Administration (DBA)
-
Master of Laws (LLM) in Patent and Technology Law
-
Bachelor of Science degree in Industrial Chemistry
Connect on LinkedIn for insights and networking
Expertise and Achievements
Major career achievements include:
-
Identified 11 patent infringement cases that generated over US$200 million in value for Novartis.
-
Led the execution of patent out-licensing initiatives, resulting in US$650 million in royalties and cost savings for Novartis.
-
Conducted in-depth competitive intelligence that directly influenced Clarivate’s strategic acquisition of SequenceBase.
-
Oversaw the post-acquisition integration of SequenceBase with Derwent Innovation, streamlining customer workflows and driving a 10%+ increase in new subscriptions.
-
Directed the integration of SequenceBase with Clarivate’s Life Science databases, enriching patented biosequence data with value-added commercial, clinical, regulatory, agrochemical, and plant biotechnology insights.
